Prediction of Ovarian Neoplasm by TVU Morphology Results and CA 125 Levels
Principal Investigator
About this CDAS Project
Study
PLCO
(Learn more about this study)
Project ID
2006-0199
Initial CDAS Request Approval
Jul 1, 2006
Title
Prediction of Ovarian Neoplasm by TVU Morphology Results and CA 125 Levels
Summary
To determine the risk of malignancy in the 1604 women found to have abnormal CA125 and/or transvaginal ultrasound
(TVU) at the initial screen and the 1566 women found to have an abnormal result at subsequent screens among the
39,115 women receiving both tests and having ovaries present in the intervention arm of the Prostate, Lung, Colorectal,
and Ovarian (PLCO) Cancer Screening Trial.
(TVU) at the initial screen and the 1566 women found to have an abnormal result at subsequent screens among the
39,115 women receiving both tests and having ovaries present in the intervention arm of the Prostate, Lung, Colorectal,
and Ovarian (PLCO) Cancer Screening Trial.
Aims
In this large trial, a positive screen was defined as CA125 > 35 U/ml; ovarian or cyst volume > 10cm3; or, solid areas,
papillary projections, or mixed components within a cystic ovarian tumor of any size. We attempted to determine further
criteria for establishing risk of malignancy in asymptomatic postmenopausal women following an abnormal screen, and
calculated sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of the
criteria.
Related Publications
-
Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial.
Partridge EE, Greenlee RT, Riley TL, Commins J, Ragard L, Xu JL, Buys SS, Prorok PC, Fouad MN
Obstet Gynecol. 2013 Jan; Volume 121 (Issue 1): Pages 25-31 PUBMED